Coexistence of ulcerative colitis and neurofibromatosis type 1: a case report and literature review

溃疡性结肠炎合并1型神经纤维瘤病:病例报告及文献综述

阅读:1

Abstract

BACKGROUND: Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder resulting from mutations in the NF1 gene, while ulcerative colitis (UC) is a chronic inflammatory disease of the intestines with an unclear etiology. Herein, we report a case involving an elderly male patient with both UC and NF1. CASE PRESENTATION: The patient experienced chronic diarrhea and mucopurulent bloody stools, leading to a confirmed diagnosis of UC through colonoscopy and histopathological examination. Treatment with corticosteroids, vedolizumab, and five-flavor sophora flavescens enteric-coated capsules (SFEC), a traditional Chinese medicine, successfully achieved remission. During the physical examination, the patient exhibited axillary café-au-lait spots, scoliosis, and multiple subcutaneous nodules on the head, trunk, and limbs. Imaging and histopathological analysis identified these nodules as neurofibromas, fulfilling the diagnostic criteria for NF1. Key features of this case include the steroid-dependent nature of the UC, which significantly improved with the combination therapy of vedolizumab and SFEC, as well as the presence of neurofibromas affecting the intestines and greater omentum. Furthermore, colonic ulcers and polypoid lesions may have been linked to the neurofibromas, while histopathological findings in both skin and intestinal tissues indicated the involvement of mast cells. This case illustrates the intricate relationship between UC and NF1, supporting a common inflammatory mechanism that may involve mast cells. CONCLUSION: This case highlights the importance of clinicians being aware of the rare coexistence of UC and NF1 to ensure accurate diagnosis and appropriate management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。